Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-20-087366
Date:2020-07-27
Issuer: SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Original Submission Date:

Reporting Person:

KHATTAR JACK A.
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE ROCKVILLE, MD 20850

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-07-27 A 15,625 a $0.00 506,466 direct
COMMON STOCK 2020-07-27 0 $0.00 1,068,450 indirect
COMMON STOCK 2020-07-27 0 $0.00 4,000 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the reporting person disclaims beneficial ownership of the shares held by his son, who shares the reporting person's household, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of section 16 or for any other purpose.
WhaleWisdom Logo

Elevate your investments